Facebook Linkedin RSS Twitter Youtube
Home 2024

Antisense oligonucleotides

DNA Origami Selectively Triggers Cytotoxicity to Make Cancer Fold
Cancer

DNA Origami Selectively Triggers Cytotoxicity to Make Cancer Fold

CatSci Acquires Specialist Chromatography Provider Reach Separations
Bioprocessing

CatSci Acquires Specialist Chromatography Provider Reach Separations

Sugar Rush: New Chemical Modification Improves ASO Targeting of CNS
Drug Discovery

Sugar Rush: New Chemical Modification Improves ASO Targeting of CNS

ASO Therapy Repairs Neurons from Timothy Syndrome Patients
Drug Discovery

ASO Therapy Repairs Neurons from Timothy Syndrome Patients

Asahi Kasei and Axolabs Partner on Oligonucleotide Therapeutics
Bioprocessing

Asahi Kasei and Axolabs Partner on Oligonucleotide Therapeutics

Rare Disease Therapeutics: Accelerating Development and Improving Access
Drug Discovery

Rare Disease Therapeutics: Accelerating Development and Improving Access

Utility of Antisense Oligonucleotides (ASOs) in Next-Generation Biotherapeutics
Insights

Utility of Antisense Oligonucleotides (ASOs) in Next-Generation Biotherapeutics

How Oligonucleotide Therapeutics May Change the Course of Rare Diseases
Drug Discovery

How Oligonucleotide Therapeutics May Change the Course of Rare Diseases

Custom ASOs Develop into Mass Producible Gene Therapies
Artificial Intelligence

Custom ASOs Develop into Mass Producible Gene Therapies

Oligonucleotide Therapeutics: New Analytical Tools and Applications
Drug Discovery

Oligonucleotide Therapeutics: New Analytical Tools and Applications

123...7Page 1 of 7
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.